The Joint Corp (JYNT) — insider trading
Health Care · NASDAQ
The Joint Corp (JYNT) has 12 reported SEC Form 4 insider transactions in our data, including 4 open-market purchases among the most recent 12 (latest 2026-06-10).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-10 | Bowman Scott Justin | Officer (Chief Financial Officer) | Shares withheld for taxes / exercise cost | 1,392 | $8.43 | $11.7K | Form 4 |
| 2026-05-20 | Pant Milind | Director | Grant / award / vesting | 5,714 | $0.00 | $0 | Form 4 |
| 2026-05-20 | Rubel Matthew E | Director | Grant / award / vesting | 5,714 | $0.00 | $0 | Form 4 |
| 2026-05-20 | DaVella Ronald V | Director | Grant / award / vesting | 5,714 | $0.00 | $0 | Form 4 |
| 2026-05-20 | Grandpre Christopher M | Director | Grant / award / vesting | 5,714 | $0.00 | $0 | Form 4 |
| 2026-05-20 | Karrmann Sandra R | Director | Grant / award / vesting | 5,714 | $0.00 | $0 | Form 4 |
| 2026-05-13 | JOBSON CHARLES E | 10% owner | Open-market purchase | 20,375 | $8.57 | $174.6K | Form 4 |
| 2026-05-12 | JOBSON CHARLES E | 10% owner | Open-market purchase | 127,676 | $8.57 | $1.09M | Form 4 |
| 2026-04-21 | JOBSON CHARLES E | 10% owner | Open-market purchase | 509 | $8.58 | $4.4K | Form 4 |
| 2026-03-09 | Razdan Sanjiv Kumar | Director, Officer (See Remarks) | Grant / award / vesting | 73,484 | $0.00 | $0 | Form 4 |
| 2026-03-09 | Bowman Scott Justin | Officer (Chief Financial Officer) | Grant / award / vesting | 28,301 | $0.00 | $0 | Form 4 |
| 2026-02-12 | JOBSON CHARLES E | 10% owner | Open-market purchase | 15,397 | $8.50 | $130.9K | Form 4 |
Ask the chat about JYNT's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: The Joint Corp (JYNT).
Last updated 2026-06-10 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.